Skip to main content
Equibles
NUS logo

NUS · Nu Skin Enterprises, Inc.

Track NUS — free

Use NUS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NUS

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.73 +0.08 (+1.72%)
Market Cap
$230.73M
Shares
48.68M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.65 Open$4.76 Day$4.53–4.78 52W close$4.65–12.84 Avg vol 30d611K Short int4.6M · 9.5% float · 10.0d Short vol67% Last earningsAug 10, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 11, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 10, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 16 · calm Equity put/call 0.58
      Technical
      price trend
      Strong Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −40%
      below
      Price vs 50-day avg −9%
      below
      RSI (14) 36
      neutral
      MACD trend Negative
      52-week position 0%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −8%
      trailing
      6-month return −45%
      trailing
      YTD return −52%
      this year
      Relative strength −56%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $5 › 200d $8 — 200d above 50d
      Institutional flow Distributing
      -10% holders QoQ · +26 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      9.50% of float · ▲ +10.5% MoM · 10.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      161 holders — near 3-yr low, contrarian setup
      Squeeze score 67
      elevated · 0–100
      Fundamentals
      Excellent
      Revenue growth +49%
      Y/Y
      Gross margin 32%
      contracting
      EPS growth +208%
      Y/Y
      Free cash flow $46.0M
      Buyback $137.3M
      remaining
      Balance sheet $14.4M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 47%
      annualized · 1-yr
      Max drawdown −64%
      past year
      ATR 5.2%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 5 of last 8
      Latest guidance · from the 8-K filed May 7, 2026
      2026 EPS · 2026 $0.70 – $1.10
      2026 EPS excluding certain charges · 2026 $0.80 – $1.20
      Prior guidance period ended · from the 8-K filed May 7, 2026
      Q2 2026 EPS · Q2 2026 $0.15 – $0.25
      Guided vs delivered · last 8 settled
      Revenue 2024
      guided $1.73B – $1.87B
      $1.73B In line
      Earnings per share 2024
      guided $0.77 – $1.16
      $-2.95 Miss −405.7%
      Revenue second quarter
      guided $420M – $455M
      $439.08M In line
      Reported earnings per share second quarter
      guided $0.01 – $0.10
      $-2.38 Miss −4427.3%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Sell
      4 · 3 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −40% Bearish
      Price vs 50-day avg
      −9% Bearish
      RSI (14)
      36 Neutral
      MACD trend
      Negative Bearish
      52-week position
      0% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $5 › 200d $8 — 200d above 50d
      Institutional flow Distributing
      -10% holders QoQ · +26 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      9.50% of float · ▲ +10.5% MoM · 10.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      161 holders — near 3-yr low, contrarian setup
      Price context
      position in its 52-week range
      Range low $5 Now $5 · 0% Range high $13
      vs 200-day avg -40% vs 50-day avg -9%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted net income non-GAAP $9.95M Q2 FY2026 —
      Adjusted operating income non-GAAP $19.56M Q2 FY2026 —
      Diluted earnings per share, excluding impact of certain charges non-GAAP $0.2 Q2 FY2026 —
      Paid Affiliates - Americas 27,337 Q2 FY2026 —
      Paid Affiliates - Europe & Africa 13,307 Q2 FY2026 —
      Paid Affiliates - Hong Kong/Taiwan 9,390 Q2 FY2026 —
      Paid Affiliates - Japan 19,018 Q2 FY2026 —
      Paid Affiliates - Mainland China 18,736 Q2 FY2026 —
      Paid Affiliates - South Korea 14,826 Q2 FY2026 —
      Paid Affiliates - Southeast Asia/Pacific 17,677 Q2 FY2026 —
      Sales Leaders - Americas 5,041 Q2 FY2026 —
      Sales Leaders - Europe & Africa 2,216 Q2 FY2026 —
      Sales Leaders - Japan 5,782 Q2 FY2026 —
      Sales Leaders - Mainland China 5,899 Q2 FY2026 —
      Sales Leaders - Southeast Asia/Pacific 3,631 Q2 FY2026 —
      EPS excluding Mavely gain and other charges non-GAAP $1.27 FY2025 —
      EPS excluding restructuring and other charges non-GAAP $0.38 Q4 2025 —
      Revenue excluding Mavely 2024 revenue non-GAAP -10.7% FY2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Household & Personal Products — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      NUS
      Nu Skin Enterprises, Inc.
      this stock
      		$230.73M -51.7% +49.0% — 9.5%
      PG
      PROCTER & GAMBLE Co
      		 $335.60B -0.2% +3.3% 21.8 1.2%
      UL
      Unilever PLC
      		 $136.52B -3.1% — — 0.1%
      CL
      Colgate Palmolive Co
      		 $71.51B +13.5% +1.7% 35.5 2.2%
      RBGLY
      Reckitt Benckiser Group PLC
      		 $43.52B — — — 0.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      161
      % held
      74.5%
      Net QoQ
      -119.5K sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      193
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      4.6M
      Days to cover
      10.0d
      Change
      +440.4K sh
      View
      Short Volume
      Short vol %
      67%
      As of
      Aug 21, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      59
      Value
      $309
      As of
      Jul 20, 2026
      View
      Off-Exchange
      Off-exchange %
      34.6%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $1.5B
      Net income (FY)
      $160.2M
      EPS diluted
      $3.18
      View
      Buybacks
      Authorized
      $500.0M
      Remaining
      $137.3M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 21, 2026
      This year
      13
      View
      Proposed Sales
      Value
      $40.5K
      Shares
      7.2K
      Filed
      Jun 2, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 10, 2026
      View
      Investor Relations
      Latest news
      Nu Skin Enterprises Reports Secon…
      Published
      Aug 10, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      NUS -4.1% -8.5% -45.2% -10.4% -51.7%
      SPY -2.0% +3.3% +11.2% +2.1% +11.8%
      vs SPY -2.2% -11.8% -56.3% -12.5% -63.5%

      Capital returns

      Latest dividend
      $0.06 / share · ex May 29, 2026
      Declared · upcoming
      $0.06 / share · ex Aug 28, 2026
      Cut 84.6%
      Paid (TTM)
      $0.24 / share · 4 payouts
      Dividend yield (TTM, derived)
      5.16%
      Buyback program · as of Aug 10, 2026
      Authorized
      $500.00M
      Spent (derived)
      $362.70M
      Remaining
      $137.30M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1021561 CUSIP 67018T105 13F (30d) 151 filings 151 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)